Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations

Blood

Volumn 129, Issue 8, 2017, Pages 1042-1045

  Curiel Olmo, Soraya ^a   Mondéjar, Rufino ^a   Almaraz, Carmen ^a   Mollejo, Manuela ^b   Cereceda, Laura ^a   Marès, Roso ^a   Derdak, Sophia ^c,d,e   Campos Martín, Yolanda ^b   Batlle, Ana ^a   De Villambrosía, Sonia González ^a   Gut, Marta ^c,d,e   Blanc, Julie ^c,d,e   Traverse Glehen, Alexandra ^f   Verney, Aurelie ^f   Baseggio, Lucile ^g   Camacho, Francisca I ^h   Wotherspoon, Andrew ⁱ   Stamatopoulos, Kostas ^j   Xochelli, Aliki ^j   Papadaki, Theodora ^k   Kanellis, George ^k   Ponzoni, Maurilio ^l   García Cosío, Monica ^m   Vaqué, Jose P ^a,n,o   Beltrán, Sergi ^c,d,e   Gut, Ivo ^c,d,e   Piris, Miguel Angel ^a,p   Martínez, Nerea ^a   more..

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^d BARCELONA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f UNIVERSITÉ DE LYON   (France)

^g HOSPICES CIVILS DE LYON   (France)

^h HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^j INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^k EVANGELISMOS HOSPITAL   (Greece)

^l SAN RAFFAELE HOSPITAL   (Italy)

^m HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁿ University of Cantabria   (Spain)

^o UNIVERSITY OF CANTABRIA   (Spain)

^p Hospital UniversitarioFundación Jiménez Díaz   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; CCND3 PROTEIN, HUMAN;

B CELL LYMPHOMA; EXOME; GENE MUTATION; HUMAN; LETTER; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; SOMATIC MUTATION; SPLENIC DIFFUSE RED PULP LYMPHOMA; WHOLE EXOME SEQUENCING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTATION; PATHOLOGY; SPLEEN TUMOR;

CYCLIN D3; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; MUTATION; SPLENIC NEOPLASMS;

EID: 85014945744     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-11-751024     Document Type: Letter

References (25)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
2. Kanellis G, Mollejo M, Montes-Moreno S, et al. Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica. 2010;95(7):1122-1129.
3. Traverse-Glehen A, Baseggio L, Bauchu EC, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood. 2008;111(4):2253-2260.
4. Martinez D, Navarro A, Martinez-Trillos A, et al. NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease. Am J Surg Pathol. 2016;40(2):192-201.
5. Traverse-Glehen A, Verney A, Gazzo S, et al. Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies [published online ahead of print June 27, 2016]. Leuk Lymphoma. doi:10.1080/10428194.2016.1196813.
6. Kiel MJ, Velusamy T, Betz BL, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012;209(9):1553-1565.
7. Rossi D, Trifonov V, Fangazio M, et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med. 2012;209(9):1537-1551.
8. Clipson A, Wang M, de Leval L, et al. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. Leukemia. 2015;29(5):1177-1185.
9. Parry M, Rose-Zerilli MJ, Ljungström V, et al. Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing. Clin Cancer Res. 2015;21(18):4174-4183.
10. Piva R, Deaglio S, Famà R, et al. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. Leukemia. 2015;29(2):503-507.
11. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364(24):2305-2315.
12. Waterfall JJ, Arons E, Walker RL, et al. High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2014;46(1):8-10.
13. Cooper AB, Sawai CM, Sicinska E, et al. A unique function for cyclin D3 in early B cell development. Nat Immunol. 2006;7(5):489-497.
14. Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298-303.
15. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011;43(9):830-837.
16. Richter J, Schlesner M, Hoffmann S, et al; ICGC MMML-Seq Project. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012;44(12):1316-1320.
17. Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM. Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med. 2014;4(2):a014282.
18. Casanovas O, Jaumot M, Paules AB, Agell N, Bachs O. P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation. Oncogene. 2004;23(45):7537-7544.
19. Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490(7418):116-120.
20. Metcalf RA, Zhao S, Anderson MW, et al. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. Mod Pathol. 2010;23(3):420-433.
21. Nakayama SYT. Parathyroid hormone-related protein-producing cyclin D3-positive blastoid variant of mantle cell lymphoma with hypercalcemia. Blood. 2016;128(14):1903.
22. Sonoki T, Harder L, Horsman DE, et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood. 2001;98(9):2837-2844.
23. Wlodarska I, Dierickx D, Vanhentenrijk V, et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood. 2008;111(12):5683-5690.
24. Salaverria I, Royo C, Carvajal-Cuenca A, et al. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood. 2013;121(8):1394-1402.
25. Dietrich S, Hüllein J, Lee SC, et al. Recurrent CDKN1B (p27) mutations in hairy cell leukemia. Blood. 2015;126(8):1005-1008.